Start a new topic

RMIP Research Spotlight - Dr. Ali Djalilian

Join us for the next RMIP Research Spotlight featuring Dr. Ali Djalilian of the University of Illinois Chicago.


Register Today for the event on Tuesday, December 15th at 2:00-3:00 PM ET. 

Dr. Ali Djalilian, MD, is a professor of ophthalmology and visual sciences at the University of Illinois Chicago, where he serves as the Director of the Corneal Stem Cell and Tissue Engineering Laboratory. Dr. Djalilian’s research focuses on advancing regenerative therapies, corneal diseases, and ocular surface injury repair by investigating key cellular and molecular pathways, stem cell secretomes, cellular senescence in chemical eye injuries, and bioadhesive hydrogels. By bridging basic science with translational clinical trials, his work aims to pioneer safe and effective treatments that improve vision, comfort, and patient outcomes for severe and difficult-to-treat ocular conditions.

Presentation Abstract: Non-healing corneal wounds are a challenging condition that can lead to significant loss of vision. Currently available therapies are limited by inability to significantly promote tissue repair and prevent pathologic responses including ulcerations/melts and scarring/fibrosis. Mesenchymal stromal cells have been shown to promote regenerative, immunomodulatory and anti-scarring effects, mediated through their secreted factors. The early-phase clinical testing to assess the safety, tolerability, and therapeutic efficacy of these bone marrow–derived mesenchymal stem cell secretome eye drops in patients with difficult-to-treat corneal conditions like aniridia, Sjögren's syndrome, and ocular GVHD. This work establishes a rigorous translational framework for advancing stem cell-derived therapies from the laboratory to the clinic, accelerating the development of regenerative treatments that can improve patient outcomes.

We hope that you will be able to join us for this spotlight. 

Login or Signup to post a comment